BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 19591973)

  • 1. [Sinonasal adenocarcinomas reviewed. Prognostic value of WHO 2005 histological classification].
    El Ayoubi A; Poizat F; Garrel R; Costes V; Guerrier B; Essakalli L; Kzadri M; Crampette L
    Ann Otolaryngol Chir Cervicofac; 2009 Sep; 126(4):175-81. PubMed ID: 19591973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma.
    Kennedy MT; Jordan RC; Berean KW; Perez-Ordoñez B
    J Clin Pathol; 2004 Sep; 57(9):932-7. PubMed ID: 15333652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Subset of Sinonasal Non-Intestinal Type Adenocarcinomas are Truly Seromucinous Adenocarcinomas: A Morphologic and Immunophenotypic Assessment and Description of a Novel Pitfall.
    Purgina B; Bastaki JM; Duvvuri U; Seethala RR
    Head Neck Pathol; 2015 Dec; 9(4):436-46. PubMed ID: 25690258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenocarcinomas of the nasal cavity and paranasal sinuses: a clinicopathological and immunohistochemical study of 14 cases.
    Abecasis J; Viana G; Pissarra C; Pereira T; Fonseca I; Soares J
    Histopathology; 2004 Sep; 45(3):254-9. PubMed ID: 15330803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of SATB2 as a Diagnostic Marker of Sinonasal Intestinal-type Adenocarcinoma.
    Skalova A; Sar A; Laco J; Metelkova A; Miesbauerova M; Steiner P; Švajdler M; Michal M
    Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):140-146. PubMed ID: 27258560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical distinction of intestinal-type sinonasal adenocarcinoma from metastatic adenocarcinoma of intestinal origin.
    Resto VA; Krane JF; Faquin WC; Lin DT
    Ann Otol Rhinol Laryngol; 2006 Jan; 115(1):59-64. PubMed ID: 16466101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CK7, CK20, SOX10 and CDX2: expressions and diagnostic values in primary adenocarcinoma of the sinonasal tract].
    Yue C; Piao Y; Bai Y; Liu H; Zhang L
    Zhonghua Yi Xue Za Zhi; 2015 Aug; 95(30):2447-50. PubMed ID: 26711206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDX-2, cytokeratin 7 and cytokeratin 20 immunohistochemical expression in the differential diagnosis of primary adenocarcinomas of the sinonasal tract.
    Franchi A; Massi D; Palomba A; Biancalani M; Santucci M
    Virchows Arch; 2004 Jul; 445(1):63-7. PubMed ID: 15175880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Among sinonasal tumors, CDX-2 immunoexpression is not restricted to intestinal-type adenocarcinomas.
    Tilson MP; Gallia GL; Bishop JA
    Head Neck Pathol; 2014 Mar; 8(1):59-65. PubMed ID: 23846317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.
    Perysinakis I; Minaidou E; Leontara V; Mantas D; Sotiropoulos GC; Tsipras H; Zografos GN; Margaris I; Kouraklis G
    Int J Surg Pathol; 2017 Feb; 25(1):31-40. PubMed ID: 27543509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adenocarcinomas of nasal cavities and paranasal sinuses: Diagnostic pitfalls in sinonasal glandular lesions].
    Poizat F; Gonzalez AM; Raynaud P; Baldet P; Garrel R; Crampette L; Costes V
    Ann Pathol; 2009 Sep; 29(4):286-95. PubMed ID: 19900634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunophenotypic differences between intestinal-type and low-grade papillary sinonasal adenocarcinomas: an immunohistochemical study of 22 cases utilizing CDX2 and MUC2.
    Cathro HP; Mills SE
    Am J Surg Pathol; 2004 Aug; 28(8):1026-32. PubMed ID: 15252308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-grade nonintestinal sinonasal adenocarcinoma: a diagnosis of exclusion.
    Bhaijee F; Carron J; Bell D
    Ann Diagn Pathol; 2011 Jun; 15(3):181-4. PubMed ID: 21393036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunohistochemical profile of colorectal and ovarian carcinomas--examination with cytokeratin 7, cytokeratin 20, beta catenin and cDX 2].
    Porjazova E; Zaprjanov Z; Batashki I; Markova D; Milchev N
    Akush Ginekol (Sofiia); 2009; 48(2):7-12. PubMed ID: 20198769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal/myoepithelial cells in chronic sinusitis, respiratory epithelial adenomatoid hamartoma, inverted papilloma, and intestinal-type and nonintestinal-type sinonasal adenocarcinoma: an immunohistochemical study.
    Ozolek JA; Barnes EL; Hunt JL
    Arch Pathol Lab Med; 2007 Apr; 131(4):530-7. PubMed ID: 17425380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of the histological classification of sinonasal intestinal-type adenocarcinomas.
    Franchi A; Gallo O; Santucci M
    Hum Pathol; 1999 Oct; 30(10):1140-5. PubMed ID: 10534159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined application of immunohistochemical markers to identify pathologic subtypes of ampullary carcinoma and its clinical significance].
    Liu FF; Shen DH; Wang HL; Ma YT; Yuan F; Liu J; Chen L; Song QJ; Zhang YY
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):92-97. PubMed ID: 30695858
    [No Abstract]   [Full Text] [Related]  

  • 18. Intestinal metaplasia of the sinonasal mucosa adjacent to intestinal-type adenocarcinoma. A morphologic, immunohistochemical, and molecular study.
    Franchi A; Palomba A; Miligi L; Ranucci V; Innocenti DR; Simoni A; Pepi M; Santucci M
    Virchows Arch; 2015 Feb; 466(2):161-8. PubMed ID: 25431194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal-type sinonasal adenocarcinomas. Immunohistochemical profile of 66 cases.
    Vivanco Allende B; Perez-Escuredo J; Fuentes Martínez N; Fresno Forcelledo MF; Llorente Pendás JL; Hermsen M
    Acta Otorrinolaringol Esp; 2013; 64(2):115-23. PubMed ID: 23122366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hierarchical clustering identifies a subgroup of colonic adenocarcinomas expressing crypt-like differentiation markers, associated with MSS status and better prognosis.
    Droy-Dupré L; Bossard C; Volteau C; Bezieau S; Laboisse CL; Mosnier JF
    Virchows Arch; 2015 Apr; 466(4):383-91. PubMed ID: 25665656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.